HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical management of intestinal obstruction after treatment for cancer. Case reports.

Abstract
Eighty-five consecutive patients operated on for malignant intestinal obstruction after earlier treatment of cancer were studied retrospectively. The overall postoperative mortality was 22% (19/85) and morbidity 42% (36/85). Intra-abdominal sepsis (N = 5) and intestinal fistula (N = 3) were the most common complications, and seven deaths were attributed primarily to the underlying malignant disease. Emergency procedures (p less than 0.003) and age greater than 70 years (p less than 0.025) were significantly associated with fatal outcome. Just over half of the patients were relieved of their symptoms. The median survival was 8 months for the 25 patients who underwent resection and 2 months for the 60 patients for whom no resection was made. The cumulative 5-year survival was significantly better for patients who underwent resection than for those who did not (p less than 0.01) and in patients with regional cancers compared with those with distant growths (p less than 0.001). We conclude that operative treatment for malignant intestinal obstruction is indicated if widespread carcinomatosis and extensive tumour growth are excluded and that this surgery should be done urgently while there is still time to resuscitate the patient.
AuthorsJ Mäkelä, H Kiviniemi, S Laitinen, M I Kairaluoma
JournalThe European journal of surgery = Acta chirurgica (Eur J Surg) Vol. 157 Issue 1 Pg. 73-7 (Jan 1991) ISSN: 1102-4151 [Print] England
PMID1675888 (Publication Type: Journal Article)
Topics
  • Abdominal Neoplasms (complications, mortality, surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Finland (epidemiology)
  • Humans
  • Intestinal Obstruction (etiology, mortality, surgery)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Postoperative Complications
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: